Replimune Group, Inc. (REPL)
9.95
-0.23
(-2.26%)
USD |
NASDAQ |
Dec 15, 16:00
10.05
+0.10
(+1.01%)
After-Hours: 05:08
Replimune Group Free Cash Flow: -269.69M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Rapt Therapeutics, Inc. | -86.66M |
| Olema Pharmaceuticals, Inc. | -134.67M |
| CorMedix, Inc. | 74.42M |
| Verastem, Inc. | -140.93M |
| Anavex Life Sciences Corp. | -39.04M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -81.21M |
| Cash from Investing (Quarterly) | 84.17M |
| Cash from Financing (Quarterly) | 0.324M |
| Free Cash Flow Per Share (Quarterly) | -0.8982 |
| Free Cash Flow to Equity (Quarterly) | -82.55M |
| Free Cash Flow to Firm (Quarterly) | -80.56M |
| Free Cash Flow Yield | -31.52% |